Skip to main content
Figure 3 | Health and Quality of Life Outcomes

Figure 3

From: Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

Figure 3

CDF of HADS score change from baseline to 24 months. a) CDF for HADS anxiety score change from baseline. b) CDF for HADS depression score change from baseline to 24 months. CDF = cumulative distribution function; HADS = Hospital Anxiety and Depression Scale Lower scores indicate lower levels of emotional distress. HADS Anxiety and Depression were not applied in Germany.

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us